Matthew Nayor1, Danielle M Enserro1, Ramachandran S Vasan1, Vanessa Xanthakis2. 1. From the Framingham Heart Study, MA (M.N., R.S.V., V.X.); Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.N.); Departments of Biostatistics (D.M.E., V.X.), Epidemiology (R.S.V., V.X.), and Sections of Preventive Medicine and Epidemiology and Cardiology, Department of Medicine (R.S.V., V.X.), Boston University School of Public Health, MA. 2. From the Framingham Heart Study, MA (M.N., R.S.V., V.X.); Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.N.); Departments of Biostatistics (D.M.E., V.X.), Epidemiology (R.S.V., V.X.), and Sections of Preventive Medicine and Epidemiology and Cardiology, Department of Medicine (R.S.V., V.X.), Boston University School of Public Health, MA. vanessax@bu.edu.
Abstract
BACKGROUND: The American Heart Association Cardiovascular Health (CVH) score is inversely associated with cardiovascular disease, but its relations to cardiac remodeling traits and heart failure (HF) incidence have not been examined. METHODS AND RESULTS: A 14-point score was constructed for each participant based on the presence of poor, intermediate, or ideal status on each of the 7 CVH metrics (ideal score=14). We related the CVH score to echocardiographic traits cross-sectionally and to HF incidence prospectively in the Framingham Offspring Study. In age- and sex-adjusted models, a higher CVH score was associated with lower left ventricular (LV) mass, LV wall thickness, LV diastolic dimension, and left atrial dimension (P<0.01 for all; n=2392; mean age, 58 years; 56% women), and with a 12% to 15% lower odds of prevalent LV concentric remodeling and concentric hypertrophy, respectively (P<0.0001 for both). On follow-up (mean, 12.3 years), 188 incident HF events were observed in 3201 participants (mean age, 59 years; 53% women). In age- and sex-adjusted Cox proportional hazard models, the CVH score was inversely associated with HF incidence (hazard ratio per 1-point higher CVH score, 0.77; 95% confidence interval, 0.72-0.83). This association was partially attenuated upon adjustment for LV mass and interim myocardial infarction (hazard ratio, 0.84; 95% confidence interval, 0.76-0.93), and it was consistent for HF with preserved and reduced ejection fractions. CONCLUSIONS: In our community-based sample, comprised predominantly of middle-aged white individuals of European descent, better CVH was associated with lower HF incidence, in part due to a lower prevalence of adverse cardiac remodeling.
BACKGROUND: The American Heart Association Cardiovascular Health (CVH) score is inversely associated with cardiovascular disease, but its relations to cardiac remodeling traits and heart failure (HF) incidence have not been examined. METHODS AND RESULTS: A 14-point score was constructed for each participant based on the presence of poor, intermediate, or ideal status on each of the 7 CVH metrics (ideal score=14). We related the CVH score to echocardiographic traits cross-sectionally and to HF incidence prospectively in the Framingham Offspring Study. In age- and sex-adjusted models, a higher CVH score was associated with lower left ventricular (LV) mass, LV wall thickness, LV diastolic dimension, and left atrial dimension (P<0.01 for all; n=2392; mean age, 58 years; 56% women), and with a 12% to 15% lower odds of prevalent LV concentric remodeling and concentric hypertrophy, respectively (P<0.0001 for both). On follow-up (mean, 12.3 years), 188 incident HF events were observed in 3201 participants (mean age, 59 years; 53% women). In age- and sex-adjusted Cox proportional hazard models, the CVH score was inversely associated with HF incidence (hazard ratio per 1-point higher CVH score, 0.77; 95% confidence interval, 0.72-0.83). This association was partially attenuated upon adjustment for LV mass and interim myocardial infarction (hazard ratio, 0.84; 95% confidence interval, 0.76-0.93), and it was consistent for HF with preserved and reduced ejection fractions. CONCLUSIONS: In our community-based sample, comprised predominantly of middle-aged white individuals of European descent, better CVH was associated with lower HF incidence, in part due to a lower prevalence of adverse cardiac remodeling.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2014-12-17 Impact factor: 29.690
Authors: Yasuhiko Takemoto; Marion E Barnes; James B Seward; Steven J Lester; Christopher A Appleton; Bernard J Gersh; Kent R Bailey; Teresa S M Tsang Journal: Am J Cardiol Date: 2005-09-15 Impact factor: 2.778
Authors: Susan R Heckbert; Wendy Post; Gregory D N Pearson; Donna K Arnett; Antoinette S Gomes; Michael Jerosch-Herold; W Gregory Hundley; Joao A Lima; David A Bluemke Journal: J Am Coll Cardiol Date: 2006-11-09 Impact factor: 24.094
Authors: Mark H Drazner; J Eduardo Rame; Emily K Marino; John S Gottdiener; Dalane W Kitzman; Julius M Gardin; Teri A Manolio; Daniel L Dries; David S Siscovick Journal: J Am Coll Cardiol Date: 2004-06-16 Impact factor: 24.094
Authors: Faraz S Ahmad; Hongyan Ning; Jonathan D Rich; Clyde W Yancy; Donald M Lloyd-Jones; John T Wilkins Journal: JACC Heart Fail Date: 2016-10-12 Impact factor: 12.035
Authors: Abbi D Lane-Cordova; Kiarri Kershaw; Kiang Liu; David Herrington; Donald M Lloyd-Jones Journal: Am J Hypertens Date: 2017-08-01 Impact factor: 2.689
Authors: Oyomoare L Osazuwa-Peters; R J Waken; Karen L Schwander; Yun Ju Sung; Paul S de Vries; Sarah M Hartz; Daniel I Chasman; Alanna C Morrison; Laura J Bierut; Chengjie Xiong; Lisa de Las Fuentes; D C Rao Journal: Genet Epidemiol Date: 2020-03-29 Impact factor: 2.135
Authors: Parveen K Garg; Wesley T O'Neal; Adedotun Ogunsua; Evan L Thacker; George Howard; Elsayed Z Soliman; Mary Cushman Journal: Am J Cardiol Date: 2017-10-19 Impact factor: 2.778